Prevention

There is no clear benefit from allocating therapy on the basis of electrophysiologic testing ^d

Why?

• Allocated anti-arrhythmic medication on the basis of electrophysiologic testing compared with Holter monitoring is not clearly less likely to have recurrent arrhythmias and is worse at predicting long-term efficacy. ^a